Stock Quotes in this Article: CYTK, ONVO, TXMD

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Read More: Triple Your Gains With These 5 Cash-Rich Companies

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Read More: 5 Stocks Ready for Breakouts

Organovo

Organovo (ONVO), a development-stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, in biological research and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. This stock closed up 1.9% to $8 in Tuesday's trading session.

Tuesday's Range: $7.85-$8.14

52-Week Range: $4.96-$13.65

Tuesday's Volume: 843,000

Three-Month Average Volume: 1.39 million

From a technical perspective, ONVO jumped notably higher here right above its 50-day moving average of $7.68 with lighter-than-average volume. This uptick higher is starting to push shares of ONVO within range of triggering a near-term breakout trade. That trade will hit if ONVO manages to clear Tuesday's intraday high of $8.14 to $8.35 and then once it takes out its 200-day moving average of $8.40 with high volume.

Traders should now look for long-biased trades in ONVO as long as it's trending above its 50-day at $7.68 or above more near-term support at $7.65 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.39 million shares. If that breakout triggers soon, then ONVO will set up to re-test or possibly take out its next major overhead resistance levels at $8.84 to $9.25. Any high-volume move above $9.25 to $9.30 will then give ONVO a chance to tag $10 to $10.50.

TherapeuticsMD

TherapeuticsMD (TXMD), a women's health care product company, manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics. This stock closed up 1.6% to $5.45 in Tuesday's trading session.

Tuesday's Range: $5.28-$5.72

52-Week Range: $2.03-$9.01

Tuesday's Volume: 2.93 million

Three-Month Average Volume: 1.85 million

From a technical perspective, TXMD jumped notably higher here right above its 200-day moving average of $5.10 with strong upside volume flows. This move to the upside on Tuesday is starting to push shares of TXMD within range of triggering a big breakout trade. That trade will hit if TXMD manages to take out Tuesday's intraday high of $5.72 to some more near-term overhead resistance at $5.80 with high volume.

Traders should now look for long-biased trades in TXMD as long as it's trending above its 200-day at $5.10 or above $5 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.85 million shares. If that breakout hits soon, then TXMD will set up to re-test or possibly take out its next major overhead resistance levels at $6.50 to $7, or even $7.50.

Cytokinetics

Cytokinetics (CYTK), a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. This stock closed up 1.3% to $4.39 in Tuesday's trading session.

Tuesday's Range: $4.27-$4.46

52-Week Range: $3.96-$13.26

Tuesday's Volume: 561,000

Three-Month Average Volume: 646,292

From a technical perspective, CYTK moved modestly higher here with decent upside volume flows. This stock has been trending sideways and consolidating for the last month and change, with shares moving between $4.05 on the downside and $4.71 on the upside. Shares of CYTK are now starting to move within range of triggering a near-term breakout trade above the upper-end of its recent sideways trading chart pattern. That trade will hit if CYTK manages to take out its 50-day moving average of $4.55 to some more resistance at $4.71 with high volume.

Traders should now look for long-biased trades in CYTK as long as it's trending above some key near-term support levels at $4.08 or at $4.05 and then once it sustains a move or close above those breakout levels volume that hits near or above 646,292 shares. If that breakout materializes soon, then CYTK will set up to re-test or possibly take out its next major overhead resistance levels at $5.09 to $5.30. Any high-volume move above $5.30 will then give CYTK a chance to re-fill some of its previous gap-down-day zone from April that started at $13.26.

To see more stocks that are making notable moves higher, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.


RELATED LINKS:







Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including

CNBC.com and Forbes.com.

You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.